This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Mar;42(3):316-7.

doi: 10.1136/gut.42.3.316.

Octreotide in hepatocellular carcinoma

D Shouval¹

Affiliations

PMID: 9577332
PMCID: PMC1727018
DOI: 10.1136/gut.42.3.316

Comment

Octreotide in hepatocellular carcinoma

D Shouval. Gut. 1998 Mar.

. 1998 Mar;42(3):316-7.

doi: 10.1136/gut.42.3.316.

Author

D Shouval¹

Affiliation

¹ Liver Unit, Hadassah University Hospital, Jerusalem, Israel.

PMID: 9577332
PMCID: PMC1727018
DOI: 10.1136/gut.42.3.316

No abstract available

PubMed Disclaimer

Comment on

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON. Kouroumalis E, et al. Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442. Gut. 1998. PMID: 9577356 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information